Top Markets
Coin of the day
XORTX Therapeutics Inc. XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTX
Pozycja w akcjach #39281
Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm... Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
Cena akcji
$2.06
Ostatnia synchronizacja: 2026-08-11
Kapitalizacja rynkowa
$572.30K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-90.38%
Kraj
CA
Handel XORTX Therapeutics Inc. (XRTX)

Kategoria

Historia stopy dywidendy dla XORTX Therapeutics Inc. (XRTX)
Stopa dywidendy (TTM) dla XORTX Therapeutics Inc. (symbol akcji: XRTX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla XORTX Therapeutics Inc. (XRTX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji